1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Closed Cell Processing Systems for Cell Therapy Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Closed Cell Processing Systems for Cell Therapy by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Closed Cell Processing Systems for Cell Therapy by Country/Region, 2018, 2022 & 2029
2.2 Closed Cell Processing Systems for Cell Therapy Segment by Type
2.2.1 Autologous Cells
2.2.2 Allogeneic Cells
2.3 Closed Cell Processing Systems for Cell Therapy Sales by Type
2.3.1 Global Closed Cell Processing Systems for Cell Therapy Sales Market Share by Type (2018-2023)
2.3.2 Global Closed Cell Processing Systems for Cell Therapy Revenue and Market Share by Type (2018-2023)
2.3.3 Global Closed Cell Processing Systems for Cell Therapy Sale Price by Type (2018-2023)
2.4 Closed Cell Processing Systems for Cell Therapy Segment by Application
2.4.1 Commercial Production
2.4.2 Laboratory/R&D Environment
2.5 Closed Cell Processing Systems for Cell Therapy Sales by Application
2.5.1 Global Closed Cell Processing Systems for Cell Therapy Sale Market Share by Application (2018-2023)
2.5.2 Global Closed Cell Processing Systems for Cell Therapy Revenue and Market Share by Application (2018-2023)
2.5.3 Global Closed Cell Processing Systems for Cell Therapy Sale Price by Application (2018-2023)
3 Global Closed Cell Processing Systems for Cell Therapy by Company
3.1 Global Closed Cell Processing Systems for Cell Therapy Breakdown Data by Company
3.1.1 Global Closed Cell Processing Systems for Cell Therapy Annual Sales by Company (2018-2023)
3.1.2 Global Closed Cell Processing Systems for Cell Therapy Sales Market Share by Company (2018-2023)
3.2 Global Closed Cell Processing Systems for Cell Therapy Annual Revenue by Company (2018-2023)
3.2.1 Global Closed Cell Processing Systems for Cell Therapy Revenue by Company (2018-2023)
3.2.2 Global Closed Cell Processing Systems for Cell Therapy Revenue Market Share by Company (2018-2023)
3.3 Global Closed Cell Processing Systems for Cell Therapy Sale Price by Company
3.4 Key Manufacturers Closed Cell Processing Systems for Cell Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Closed Cell Processing Systems for Cell Therapy Product Location Distribution
3.4.2 Players Closed Cell Processing Systems for Cell Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Closed Cell Processing Systems for Cell Therapy by Geographic Region
4.1 World Historic Closed Cell Processing Systems for Cell Therapy Market Size by Geographic Region (2018-2023)
4.1.1 Global Closed Cell Processing Systems for Cell Therapy Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Closed Cell Processing Systems for Cell Therapy Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Closed Cell Processing Systems for Cell Therapy Market Size by Country/Region (2018-2023)
4.2.1 Global Closed Cell Processing Systems for Cell Therapy Annual Sales by Country/Region (2018-2023)
4.2.2 Global Closed Cell Processing Systems for Cell Therapy Annual Revenue by Country/Region (2018-2023)
4.3 Americas Closed Cell Processing Systems for Cell Therapy Sales Growth
4.4 APAC Closed Cell Processing Systems for Cell Therapy Sales Growth
4.5 Europe Closed Cell Processing Systems for Cell Therapy Sales Growth
4.6 Middle East & Africa Closed Cell Processing Systems for Cell Therapy Sales Growth
5 Americas
5.1 Americas Closed Cell Processing Systems for Cell Therapy Sales by Country
5.1.1 Americas Closed Cell Processing Systems for Cell Therapy Sales by Country (2018-2023)
5.1.2 Americas Closed Cell Processing Systems for Cell Therapy Revenue by Country (2018-2023)
5.2 Americas Closed Cell Processing Systems for Cell Therapy Sales by Type
5.3 Americas Closed Cell Processing Systems for Cell Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Closed Cell Processing Systems for Cell Therapy Sales by Region
6.1.1 APAC Closed Cell Processing Systems for Cell Therapy Sales by Region (2018-2023)
6.1.2 APAC Closed Cell Processing Systems for Cell Therapy Revenue by Region (2018-2023)
6.2 APAC Closed Cell Processing Systems for Cell Therapy Sales by Type
6.3 APAC Closed Cell Processing Systems for Cell Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Closed Cell Processing Systems for Cell Therapy by Country
7.1.1 Europe Closed Cell Processing Systems for Cell Therapy Sales by Country (2018-2023)
7.1.2 Europe Closed Cell Processing Systems for Cell Therapy Revenue by Country (2018-2023)
7.2 Europe Closed Cell Processing Systems for Cell Therapy Sales by Type
7.3 Europe Closed Cell Processing Systems for Cell Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Closed Cell Processing Systems for Cell Therapy by Country
8.1.1 Middle East & Africa Closed Cell Processing Systems for Cell Therapy Sales by Country (2018-2023)
8.1.2 Middle East & Africa Closed Cell Processing Systems for Cell Therapy Revenue by Country (2018-2023)
8.2 Middle East & Africa Closed Cell Processing Systems for Cell Therapy Sales by Type
8.3 Middle East & Africa Closed Cell Processing Systems for Cell Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Closed Cell Processing Systems for Cell Therapy
10.3 Manufacturing Process Analysis of Closed Cell Processing Systems for Cell Therapy
10.4 Industry Chain Structure of Closed Cell Processing Systems for Cell Therapy
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Closed Cell Processing Systems for Cell Therapy Distributors
11.3 Closed Cell Processing Systems for Cell Therapy Customer
12 World Forecast Review for Closed Cell Processing Systems for Cell Therapy by Geographic Region
12.1 Global Closed Cell Processing Systems for Cell Therapy Market Size Forecast by Region
12.1.1 Global Closed Cell Processing Systems for Cell Therapy Forecast by Region (2024-2029)
12.1.2 Global Closed Cell Processing Systems for Cell Therapy Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Closed Cell Processing Systems for Cell Therapy Forecast by Type
12.7 Global Closed Cell Processing Systems for Cell Therapy Forecast by Application
13 Key Players Analysis
13.1 Thermofisher
13.1.1 Thermofisher Company Information
13.1.2 Thermofisher Closed Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.1.3 Thermofisher Closed Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Thermofisher Main Business Overview
13.1.5 Thermofisher Latest Developments
13.2 Shenzhen Eureka Biotechnology
13.2.1 Shenzhen Eureka Biotechnology Company Information
13.2.2 Shenzhen Eureka Biotechnology Closed Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.2.3 Shenzhen Eureka Biotechnology Closed Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shenzhen Eureka Biotechnology Main Business Overview
13.2.5 Shenzhen Eureka Biotechnology Latest Developments
13.3 Cytiva (Danaher)
13.3.1 Cytiva (Danaher) Company Information
13.3.2 Cytiva (Danaher) Closed Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.3.3 Cytiva (Danaher) Closed Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Cytiva (Danaher) Main Business Overview
13.3.5 Cytiva (Danaher) Latest Developments
13.4 Miltenyi Biotec
13.4.1 Miltenyi Biotec Company Information
13.4.2 Miltenyi Biotec Closed Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.4.3 Miltenyi Biotec Closed Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Miltenyi Biotec Main Business Overview
13.4.5 Miltenyi Biotec Latest Developments
13.5 FloDesign Sonics
13.5.1 FloDesign Sonics Company Information
13.5.2 FloDesign Sonics Closed Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.5.3 FloDesign Sonics Closed Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 FloDesign Sonics Main Business Overview
13.5.5 FloDesign Sonics Latest Developments
13.6 Terumo Corporation
13.6.1 Terumo Corporation Company Information
13.6.2 Terumo Corporation Closed Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.6.3 Terumo Corporation Closed Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Terumo Corporation Main Business Overview
13.6.5 Terumo Corporation Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Closed Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.7.3 Fresenius Kabi Closed Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Sartorius AG
13.8.1 Sartorius AG Company Information
13.8.2 Sartorius AG Closed Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.8.3 Sartorius AG Closed Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sartorius AG Main Business Overview
13.8.5 Sartorius AG Latest Developments
13.9 ThermoGenesis Holdings, Inc.
13.9.1 ThermoGenesis Holdings, Inc. Company Information
13.9.2 ThermoGenesis Holdings, Inc. Closed Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.9.3 ThermoGenesis Holdings, Inc. Closed Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ThermoGenesis Holdings, Inc. Main Business Overview
13.9.5 ThermoGenesis Holdings, Inc. Latest Developments
13.10 Lonza
13.10.1 Lonza Company Information
13.10.2 Lonza Closed Cell Processing Systems for Cell Therapy Product Portfolios and Specifications
13.10.3 Lonza Closed Cell Processing Systems for Cell Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Lonza Main Business Overview
13.10.5 Lonza Latest Developments
14 Research Findings and Conclusion
| ※参考情報 細胞治療用クローズドセル処理システムは、細胞治療における重要な技術の一つであり、細胞の収集、処理、保存、投与に至るまでの一連のプロセスを効率的かつ安全に行うことを目的としています。このシステムの主な特徴は、細胞操作の全過程を無菌状態で行うことができる点にあります。細胞治療は、特定の疾患に対して患者自身の細胞を用いる治療法であり、最近ではがんや自己免疫疾患、心血管疾患などに対する新たな治療法として注目されています。そのため、細胞の品質と安全性を確保するためには、適切な処理システムが不可欠です。 このクローズドセル処理システムの定義は、細胞や生体材料を外部環境から隔離された状態で扱う技術を指します。オープンシステムと対比される形で、外部の影響を最小限に抑えることができるため、感染のリスクを減少させ、細胞の機能を保持することが可能になります。これにより、治療に用いる細胞が高品質であることが保証され、治療効果の向上が期待されています。 このシステムの特長として、まず第一に無菌操作が挙げられます。細胞を無菌状態で処理することで、外部からの微生物汚染を防ぎます。さらに、クローズドシステムは、特定の生物学的環境を保つことができるため、細胞の成長や機能が最大限に引き出される条件を整えることができます。また、操作が自動化されている場合が多く、作業者の負担を軽減するとともに、ヒューマンエラーのリスクを低減します。これにより、製品の標準化や再現性も向上し、製造工程が効率的に進行します。 次に、クローズドセル処理システムの種類について述べます。主に、流体システム、カセットシステム、バイアルシステムなどが挙げられます。流体システムは、細胞や試薬を管から流すことで処理を行うもので、連続した処理が可能なため、高い生産性を持つという特長があります。カセットシステムは、特定の形状に細胞をセットして処理を行うもので、取り扱いやすく、迅速な操作が可能です。バイアルシステムでは、細胞を密閉されたバイアル内で処理するため、外部環境の影響を受けにくいという利点があります。 このシステムの用途は、主に細胞治療の分野で広く利用されています。特に、CAR-T細胞療法や幹細胞治療など、高度な技術を必要とする治療法において重要な役割を果たしています。CAR-T細胞療法では、患者のT細胞を採取し、遺伝子改変を行った後に患者に戻すというプロセスがありますが、この途中での無菌処理が極めて重要です。また、幹細胞治療においても、幹細胞の選別や培養、凍結保存などの工程でクローズドシステムが用いられています。 関連技術としては、細胞培養技術、遺伝子編集技術、バイオインフォマティクス、ロボティクスなどがあります。細胞培養技術は、細胞を体外で増殖させる技術であり、クローズドシステムと組み合わせることで無菌環境を保ちながら細胞を効果的に増やすことが可能です。遺伝子編集技術は、細胞の遺伝子を改変するための手法であり、特にCAR-T細胞療法において不可欠な技術です。また、バイオインフォマティクスは、細胞治療の効果を評価するためのデータ解析を行うために用いられ、細胞処理の標準化や品質管理に貢献しています。ロボティクス技術は、細胞処理の自動化を進める役割を果たし、より効率的かつ正確な細胞操作を可能にします。 このように、細胞治療用クローズドセル処理システムは、細胞治療の発展を支える基盤技術として重要な役割を果たしています。無菌環境での操作が可能であるため、細胞の品質と治療効果を最大限に引き出すことができ、将来的にはさらに多くの疾患に対する治療法の確立が期待されています。細胞治療がますます普及する中で、クローズドシステムの技術革新と進化が、さらなる治療可能性を広げることになるでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
